Stocks Fall as Iran Deal Hopes Fade Before Ceasefire Deadline
SkimNews Take
Market reactions to geopolitical events are increasingly driven by their perceived impact on energy costs, rather than broader economic fundamentals or specific sector vulnerabilities.
Get the Finance newsletter
Daily finance — markets, central banks, M&A, the prints that move money. Free.
- Markets sold off across the board: the S&P 500 fell 0.63% to 7,064.01, the Dow lost 293.18 points, and the Nasdaq declined 0.59%, with anxiety heightened by reports that VP JD Vance's trip to Iran negotiations was paused due to Tehran's lack of commitment.
- Oil prices reversed recent declines, with WTI crude jumping 2.81% to $92.13/barrel and Brent rising 3.14% to $98.48/barrel as the prospect of a peace deal receded.
- Trump announced the ceasefire would be extended until Iran submits a proposal, though he had told CNBC earlier the U.S. military is "ready" to bomb Iran if no deal is signed by the deadline.
- UnitedHealth shares surged roughly 7% after Q1 results beat Wall Street expectations and the company raised its earnings outlook.
- Amazon climbed 0.7% after agreeing to invest up to $25 billion in AI startup Anthropic.
- The Nasdaq had just ended a 13-day winning streak — its longest since 1992 — while the S&P 500 closed above 7,100 for the first time ever the prior week, underscoring the market's strong momentum before the Iran-driven pullback.
Why it matters: With a ceasefire deadline hours away and Vance's diplomatic trip paused, traders priced in a real risk of renewed U.S.-Iran hostilities — driving a 2.81–3.14% oil surge and pulling major indices lower despite strong underlying signals like UnitedHealth's 7% post-earnings rally and a Q1 earnings season expected to deliver double-digit growth.
